Pengfei Shao

2.0k citations
84 papers · 1.4k indexed · h-index 22
Topics
Renal cell carcinoma treatment (23 papers)Renal and Vascular Pathologies (17 papers)Cancer-related molecular mechanisms research (9 papers)
Partner nations
ChinaFranceChile

In The Last Decade

Pengfei Shao

80 papers receiving 1.4k citations

Peers

Pengfei Shao
Comparison fields: 5 of 112
  • Molecular Biology 738
  • Pulmonary and Respiratory Medicine 576
  • Cancer Research 411
  • Surgery 174
  • Oncology 143
Replace Kyungeun Kim with:
Kyungeun Kim South Korea
Zhigang Song China
Jeffrey E. Thatcher United States
Alexander H. Boag Canada
Hakmin Lee South Korea
Huaiyin Shi China
Tianyuan Xu China
Agnieszka Hałoń Poland
Christian Freudlsperger Germany
Tatsuo Igarashi Japan
Pengfei Shao relative to Kyungeun Kim South Korea Kyungeun Kim's profile →
Citations per field
00.5×1.5×1.9×
Kyungeun Kim · 1×
Citations per year

Countries citing papers authored by Pengfei Shao

Since Specialization
Citations

This map shows the geographic impact of Pengfei Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Shao more than expected).

Fields of papers citing papers by Pengfei Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Shao. The network helps show where Pengfei Shao may publish in the future.

Co-authorship network of co-authors of Pengfei Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Shao. A scholar is included among the top collaborators of Pengfei Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Shao. Pengfei Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 28
3 1
4 33
5 1
6 3
7 58
8 4
9 11
10 5
11 22
12 23
13 33
14 43
15 7
16 15
17 17
18 1
19 0
20 124

About Pengfei Shao

Pengfei Shao is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Urology, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (23 papers), Renal and Vascular Pathologies (17 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (411 citations), Pulmonary and Respiratory Medicine (576 citations) and Molecular Biology (738 citations). Pengfei Shao has collaborated with scholars based in China, France and Chile. Frequent co-authors include Chao Qin, Changjun Yin, Xiaobing Ju, Xiaoxin Meng, Qiang Cao, Pu Li, Qiang Lv, Lijun Tang, Hongzhou Cai and Jie Li. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026